You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EVEREST II

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Beijing, Shanghai (Phase I:[177Lu]Lu-XT033 Injection, Phase II:[177Lu]Lu-XT033 Injection)

Not yet recruiting
  • Prostate Cancer
  • Phase I:[177Lu]Lu-XT033 Injection
  • Phase II:[177Lu]Lu-XT033 Injection
  • Beijing, Beijing, China
  • +1 more
Oct 7, 2023

Advanced Solid Tumor Trial in Shanghai (JS015, Toripalimab, Paclitaxel)

Not yet recruiting
  • Advanced Solid Tumor
  • JS015
  • +10 more
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Nov 17, 2023

Bone Marrow Transplant Complications, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Adult Trial in Indianapolis

Not yet recruiting
  • Bone Marrow Transplant Complications
  • +4 more
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
May 30, 2023

Asphyxia Neonatorum, Birth Asphyxia Trial in Edmonton (Heart rate assessment using the Neonatal Resuscitation Program 6-sec

Withdrawn
  • Asphyxia Neonatorum
  • Birth Asphyxia
  • Heart rate assessment using the Neonatal Resuscitation Program 6-sec assessment method
  • Heart rate assessment using Tap-based smartphone application
  • Edmonton, Alberta, Canada
    Royal Alexandra Hospital
Sep 3, 2021

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell Trial in United Kingdom (ALETA-001)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • +4 more
  • Birmingham, United Kingdom
  • +5 more
Sep 18, 2023

Type 2 Diabetes With Peripheral Angiopathy Trial in Karachi (Concurrent Training, Aerobic Training)

Enrolling by invitation
  • Type 2 Diabetes With Peripheral Angiopathy
  • Concurrent Training
  • Aerobic Training
  • Karachi, Sindh, Pakistan
    Uroosa Amin
Sep 7, 2023

NSCLC Trial in Guangzhou (Neratinib tablets)

Not yet recruiting
  • NSCLC
  • Neratinib tablets
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 1, 2023

Septic Shock, Vasodilatory Shock Trial in Albuquerque (Angiotensin II)

Recruiting
  • Septic Shock
  • Vasodilatory Shock
  • Angiotensin II
  • Albuquerque, New Mexico
    University of New Mexico Health Sciences Center
Apr 19, 2023

Oropharyngeal Cancer, Squamous Cell Carcinoma of the Oropharynx Trial in Ann Arbor (procedure, combination product, other,

Recruiting
  • Oropharyngeal Cancer
  • Squamous Cell Carcinoma of the Oropharynx
  • Surgery
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
May 30, 2023

Biliary Tract Cancer, Cholangiocarcinoma Trial in Italy (Gemcitabine, Nab paclitaxel, Cisplatin)

Not yet recruiting
  • Biliary Tract Cancer
  • Cholangiocarcinoma
  • Ancona, Italy
  • +18 more
Sep 16, 2023

Risk Assessment in Neonatal Intensive Care Unit

Recruiting
  • Neonatal Death
  • CRIB II
  • +5 more
  • Sohag, Egypt
    Neonatal Intensive Care Units at Sohag University Hospitals
Mar 12, 2023

Metastatic Colorectal Cancer Trial in Nijmegen, Amsterdam, Groningen (Dose escalation cetuximab, Standard dose cetuximab)

Terminated
  • Metastatic Colorectal Cancer
  • Dose escalation cetuximab
  • Standard dose cetuximab
  • Nijmegen, Gelderland, Netherlands
  • +2 more
Apr 8, 2021

MSI-H Colorectal Cancer, Tislelizumab, Oxaliplatin Trial (Tislelizumab)

Not yet recruiting
  • MSI-H Colorectal Cancer
  • +3 more
  • (no location specified)
Apr 23, 2023

Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1

Not yet recruiting
  • Metastatic Clear Cell Renal Cell Carcinoma
  • With Positive PSMA Expression at Tumor Sites
  • 177Lu-PSMA-1 (radiopharmaceutical)
  • (no location specified)
Sep 26, 2023

NSCLC Trial in Shanghai (SBRT+LDRT, Toripalimab, Chemotherapy drug)

Recruiting
  • NSCLC
  • SBRT+LDRT
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Apr 2, 2023

Hepatocellular Carcinoma Trial in United States (AZD5851)

Not yet recruiting
  • Hepatocellular Carcinoma
  • AZD5851
  • Duarte, California
  • +9 more
Oct 12, 2023

Malocclusion, Angle Class II Trial in Hama (Modified Twin-Block Appliance with Clear Plates., Traditional Twin-Block appliance)

Recruiting
  • Malocclusion, Angle Class II
  • Modified Twin-Block Appliance with Clear Plates.
  • Traditional Twin-Block appliance
  • Hama, Syrian Arab Republic
    Hama University
Jul 10, 2023

Moderate to Severe Atopic Dermatitis Trial in Nanjing (VC005 tablets, VC005 Tablets Placebo)

Recruiting
  • Moderate to Severe Atopic Dermatitis
  • VC005 tablets
  • VC005 Tablets Placebo
  • Nanjing, Jiangsu, China
    Chinese Academy of Medical Sciences Hospital for Skin Diseases
Aug 16, 2023

Osteoarthritis, Knee Trial in Taipei (2ccPA, Placebo)

Recruiting
  • Osteoarthritis, Knee
  • Taipei, Taiwan
    Taipei Veterans General Hospital
Mar 28, 2023

Advanced Solid Tumor Trial in Beijing (Simmitinib, SG001)

Not yet recruiting
  • Advanced Solid Tumor
  • Beijing, Beijing, China
    Cancer Hospital,Chinese Academy of Medical Sciences and Peking U
Nov 9, 2023

Stroke, Medication Adherence Trial in Kumasi (Polycap)

Not yet recruiting
  • Stroke
  • Medication Adherence
  • Kumasi, Ghana
    Kwame Nkrumah Institute of Science & Technology
Jul 19, 2023

Liver Transplant Trial (OCS Liver)

Not yet recruiting
  • Liver Transplant
  • OCS Liver
  • (no location specified)
Jul 10, 2023

Relapsed or Refractory Non-Hodgkin's Lymphoma Trial in Changsha, Suzhou (U16)

Recruiting
  • Relapsed or Refractory Non-Hodgkin's Lymphoma
  • Changsha, Hunan, China
  • +1 more
Mar 13, 2023

Septic Shock, Acute Kidney Injury Trial in Lexington (Standard of Care, Angiotensin II)

Recruiting
  • Septic Shock
  • Acute Kidney Injury
  • Standard of Care
  • Angiotensin II
  • Lexington, Kentucky
    University of Kentucky HealthCare Chandler Medical Center
Dec 7, 2022

Inflammatory Response Trial in Melbourne (Dexamethasone)

Active, not recruiting
  • Inflammatory Response
  • Melbourne, Victoria, Australia
    Alfred Health
Jan 9, 2023